Medicina
Departamento
University of Salerno
Fisciano, ItaliaPublicaciones en colaboración con investigadores/as de University of Salerno (14)
2023
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553
2021
-
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491
2020
-
Characteristics and treatment regimens across ERS SHARP severe asthma registries
European Respiratory Journal, Vol. 55, Núm. 1
-
Impact of caloric restriction on AMPK and endoplasmic reticulum stress in peripheral tissues and circulating peripheral blood mononuclear cells from Zucker rats
Journal of Nutritional Biochemistry, Vol. 78
2017
-
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
American Heart Journal, Vol. 193, pp. 46-54
-
Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis
Clinical Microbiology and Infection, Vol. 23, Núm. 8, pp. 544-549
-
Prosthetic joints: shining lights on challenging blind spots
International Journal of Antimicrobial Agents
2016
-
Clinical, neuroradiological and molecular characterization of cerebellar dysplasia with cysts (Poretti-Boltshauser syndrome)
European Journal of Human Genetics, Vol. 24, Núm. 9, pp. 1262-1267
-
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials
Cardiovascular Revascularization Medicine, Vol. 17, Núm. 5, pp. 295-301
2015
-
Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis
Heart, Vol. 101, Núm. 19, pp. 1554-1561
-
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: A patient-level analysis of the randomized early routine invasive clinical trials
JACC: Cardiovascular Interventions, Vol. 8, Núm. 1, pp. 166-174
2014
-
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3
2013
-
HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
PLoS ONE, Vol. 8, Núm. 5
-
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke
Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 209-217